InDex Pharmaceuticals Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
InDex Pharmaceuticals General Information
Description
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.
Contact Information
Website
www.indexpharma.comCorporate Office
- Berzelius väg 13
- 171 65 Solna
- Sweden
Corporate Office
- Berzelius väg 13
- 171 65 Solna
- Sweden
InDex Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Merger/Acquisition | 10-Jun-2024 | Completed | Profitable | |||
| 13. PIPE | 19-Sep-2019 | Completed | Profitable | |||
| 12. PIPE | 29-Oct-2018 | Completed | Profitable | |||
| 11. Grant | 23-Mar-2018 | Completed | Startup | |||
| 10. PIPE | 01-Jan-2018 | Completed | Profitable | |||
| 9. IPO | 11-Oct-2016 | Completed | Profitable | |||
| 8. Grant | 23-May-2016 | Completed | Profitable | |||
| 7. Later Stage VC | 25-Feb-2014 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 21-Jan-2011 | $11.1M | $18.8M | Completed | Generating Revenue | |
| 5. Early Stage VC | 26-May-2004 | $7.73M | Completed | Startup |
InDex Pharmaceuticals Comparisons
Industry
Financing
Details
InDex Pharmaceuticals Competitors (66)
One of InDex Pharmaceuticals’s 66 competitors is ACADIA Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Hansa Biopharma | Corporation | Lund, Sweden | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Swedish Orphan Biovitrum | Formerly VC-backed | Stockholm, Sweden |
InDex Pharmaceuticals Patents
InDex Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022344527-A1 | Enema formulation | Inactive | 09-Sep-2021 | ||
| AU-2022344527-A9 | Enema formulation | Inactive | 09-Sep-2021 | ||
| CA-3209396-A1 | Enema formulation | Pending | 09-Sep-2021 | ||
| EP-4147688-A1 | Enema formulation | Inactive | 09-Sep-2021 | ||
| EP-4167962-A1 | Enema formulation | Active | 09-Sep-2021 | A61K9/0031 |
InDex Pharmaceuticals Signals
InDex Pharmaceuticals Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| CapMan | Real Estate | Minority | ||
| Angel (individual) | Minority | |||
| Fjärde AP-fonden | Limited Partner | Minority | ||
| GZ Group | Venture Capital | Minority |
InDex Pharmaceuticals Acquisitions (1)
InDex Pharmaceuticals’s most recent deal was a Reverse Merger with Flerie. The deal was made on 10-Jun-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Flerie | 10-Jun-2024 | Reverse Merger | Private Equity |
InDex Pharmaceuticals FAQs
-
When was InDex Pharmaceuticals founded?
InDex Pharmaceuticals was founded in 2000.
-
Where is InDex Pharmaceuticals headquartered?
InDex Pharmaceuticals is headquartered in Solna, Sweden.
-
What is the size of InDex Pharmaceuticals?
InDex Pharmaceuticals has 7 total employees.
-
What industry is InDex Pharmaceuticals in?
InDex Pharmaceuticals’s primary industry is Drug Discovery.
-
Is InDex Pharmaceuticals a private or public company?
InDex Pharmaceuticals is a Private company.
-
What is InDex Pharmaceuticals’s current revenue?
The current revenue for InDex Pharmaceuticals is .
-
How much funding has InDex Pharmaceuticals raised over time?
InDex Pharmaceuticals has raised $86.5M.
-
Who are InDex Pharmaceuticals’s investors?
, CapMan, , Fjärde AP-fonden, and GZ Group are 5 of 14 investors who have invested in InDex Pharmaceuticals.
-
Who are InDex Pharmaceuticals’s competitors?
ACADIA Pharmaceuticals, Hansa Biopharma, Alnylam Pharmaceuticals, Gilead, and Swedish Orphan Biovitrum are some of the 66 competitors of InDex Pharmaceuticals.
-
When was InDex Pharmaceuticals acquired?
InDex Pharmaceuticals was acquired on 10-Jun-2024.
-
Who acquired InDex Pharmaceuticals?
InDex Pharmaceuticals was acquired by Flerie.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process